Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

As one of the first multinational companies to enter China in 1982, Sanofi is committed to accelerating the introduction ... of biological products guidance for industry issued by the US FDA.

Sanofi plans to submit regulatory filings for the therapy in the US and EU this year. Credit: rafaelnlins / Shutterstock. French pharmaceutical company Sanofi has reported results from its Phase III ...

The FDA headquarters at White Oak Campus. Credit: Tada Images / Shutterstock. The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research ...

Also Read: Sanofi’s 340B Credit Proposal Draws Federal ... EU are planned during the first half of 2025. In September, the FDA approved Sarclisa (isatuximab) in combination with bortezomib ...